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ABSTRACT 
 
The therapeutic advances that have taken place since the mid 1990s have profoundly affected the 
situation of people living with HIV/AIDS, not only in terms of life expectancy and quality of life 
but also socio-economically. This has numerous effects on different aspects of the patients’ life 
and, especially, on their working life. We analyse in this paper labour force participation and 
wages of people living with HIV/AIDS in Spain. We select a control group from the general 
population. We find that the employment probability decreases by 16.4 percentage points among 
asymptomatic HIV patients, by 22.5 percentage points among symptomatic HIV patients, and as 
much as by 41.3 percentage points if the person is in the AIDS phase. In addition, wages of HIV 
patients are from 9 to 34 per cent (if infected by Intravenous Drug Use) lower. Gender, 
educational attainment, unearned income, HIV clinical indicators and number of household 
members are the main determinants of the employment probability of HIV patients. On the 
other hand, wages do not play a significant role in employment decisions of these individuals.  
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1. Introduction 
 
Following the discovery of the human immunodeficiency virus (HIV), it was feared that it 
would become one of the biggest public health challenges in decades to follow [Fauci, 1999]. 
Unfortunately, such suspicions were not unfounded. The HIV/AIDS disease has not only had a 
strong impact on the health of populations across the globe, but it also represents a serious 
socio-economic problem for many individuals, families, communities and governments [Ojo 
and Delaney, 1997; Beck et al., 2001; Hellinger, 2006; ILO, 2006; UNAIDS, 2008].  
 
The vast majority of HIV-positive people are of working age [UNAIDS, 2008]. The loss of 
workers and work-days due to AIDS-related illnesses or the demands of caring can result in 
significant declines in productivity, loss of earnings, and attrition in skills and experience [Lisk, 
2002; ILO, 2005]. Thus, HIV/AIDS is not only a public health concern but has also become a 
threat to employment objectives and labour market efficiency. 
 
Studies carried out during the 1980s and early 1990s in high-income countries pointed out that 
an HIV diagnosis had a strong impact on labour force participation. Scitovsky and Rice (1987) 
assumed that a typical AIDS patient was too ill to work for 60 per cent of his or her time. Yelin 
et al. (1991) reported that half of those working when they were informed of the diagnosis left 
work within the following two years. Massagli et al. (1994) found that in Boston 76 per cent were 
working at the moment of diagnosis, while only 53 per cent at the time of the survey (with an 
average elapsed period of 16 months between the diagnosis and the survey). Similarly, Laursen 
and Larsen (1996) found that while 50 per cent of the patients were employed when they were 
diagnosed with AIDS, this percentage fell to a 22 per cent a month after diagnosis and to 6 per 
cent two years afterwards. Leigh et al. (1995) use non-HIV individuals as a control group and 
concluded that HIV patients with and without AIDS experienced a substantial and significant 
loss of working days. 
  
The therapeutic advances made since the mid 1990s have substantially changed this panorama 
and there are some studies making this fact very clear. For example, Dray-Spira et al. (2003) 
stated that between 46.8 and 58.8 per cent of HIV+ people (depending on the region of France 
under consideration) were employed and a third of the unemployed said they were looking for 
job. Dray Spira et al (2007) pointed that the employment rate of HIV-infected patients was 25% 
lower compared to the general population if diagnosed before 1994 and 9% lower if diagnosed 
from 1994 onward. In addition, the employment rate of highly educated HIV-infected patients 
diagnosed during the second period was not statistically different from the employment rates of 
the general population. Rabkin et al. (2004) followed a sample of US patients and concluded that 
those who were employed at baseline kept their jobs, but patients who were unemployed did not 
manage to return to their jobs or find another job. Goldman and Bao (2004) studied the effect of 
the use of Highly Active Anti-Retroviral Treatments (HAARTs) on the probability of returning 
to work, keeping the same position and number of hours worked. Their results indicated that the 
probability of keeping the job in the six months after start of the treatment increased from 58 to 
94 per cent as a result of the treatment. Bernell and Shinogle (2004) stressed that HAARTs 
substantially increased the zero-positive person’s chances of participating in the labour force. 
Nevertheless, this does not mean that an HIV diagnosis does not affect the patient’s 
participation or that its impact is lesser. Auld (2002) suggested that the decrease in the 
percentage of HIV-positive people in employment is a consequence of the change in life 
expectancy following a health shock. He estimated a 25 per cent decrease on the employment 
probability after diagnosis. Recently, Galarraga et al. (2010) examined the effect of antidepressant 
use on the likelihood of being employed among HIV-positive women receiving HAART in the 
United States from 1994 to 2004. After addressing potential sources of bias, they concluded that 
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the use of antidepressants is associated with a higher probability of being employed. Sendi et al. 
(2007) suggested that the allocation of time in HIV-infected patients does not differ with level of 
education (i.e., wage rate), and that availability of non-labour income induces income effects, that 
is, individuals demand more leisure time. Last, Oliva (2010) stated that about 50 per cent of HIV 
population in Spain had a job, but there were large differences by gender, educational attainment 
and clinical stage. 
 
One can conclude that the illness has negative effects on labour force participation. The effects 
seem to be smaller after the introduction of HAART, although they are still non-negligible (Auld, 
2002). However, except for Leigh et al. (1995), none of the previous studies used a control group 
with the same distribution of socio-demographic characteristics. In this context, this paper 
contributes to the existing literature as it tests the effects of the disease on the employment 
situation and wages of HIV-positive persons using a comparable control group from the general 
population in terms of age, gender and educational attainment. We merge administrative data 
from clinical histories of Spanish HIV+ patients from Canary Islands with a subsample of the 
linked Canary Islands Health Survey and Canary Islands Survey on Income and Living 
Conditions. We propose a neoclassical model of labour supply including classical variables (age, 
gender, education, children at home, and unearned income), objective health variables (stage of 
the illness, viral count and CD4 cells count) and self reported health variables (health related 
quality of life). We think that the strategy of using a homogeneous control group together with 
the inclusion of all mentioned variables will allow us to correctly identify the effects of the health 
shock on the labour supply at the extensive margin. Our results show that the employment 
probability decreases by 16.4 percentage points among asymptomatic HIV patients, by 22.5 
percentage points among symptomatic HIV patients, and as much as by 41.3 percentage points if 
the person is in the AIDS phase.  
 
The evidence on the effect of HIV/AIDS on wages is scarcer. Auld (2002) found that HIV 
diagnosis does not have an effect on wages and the effect of CD4 counts is non-significant. We 
add to the existing evidence investigating the effect that the disease and its stage have on the 
wages. We find that wages of HIV patients are from 9% to 34% (if infected by Intravenous Drug 
Use) lower. 
 
The rest of the paper is structured as follows. The data collection process and the main features 
of the sample are described in detail in section 2. Section 3 is dedicated to the analytical 
framework, where a specification of a reduced-form participation equation is considered. We 
present in section 4 the main results and we also discuss their implications. The paper ends up 
with a summary of the main conclusions. 
 
2. Data collection and sample of analysis 
 
2.1. Population with HIV 
 
A cross-sectional multi-centre study of 572 patients diagnosed with HIV/AIDS was carried out 
in order to collect the data needed. Patients receiving outpatient care were recruited in autumn 
2003 from four hospital outpatient clinics in the Canary Islands. Individuals included in the study 
had to fulfil at least one of the following criteria: a) treated by the Infectious Diseases Unit of 
one of the different hospitals during 2003; or b) to attend a day surgery from the Infectious 
Diseases Unit of one the hospitals. We used the classification system proposed in 1993 by the 
Centre for Disease Control (CDC) in the United States to classify the severity of the HIV 
infection into asymptomatic HIV, symptomatic HIV and AIDS (Ancelle Park, 1993). 
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We use data from the patients' medical records and self-completed questionnaires. Employment 
information was collected using a questionnaire previously tested in a pilot study (Oliva et al., 
2003). 400 questionnaires were posted to the home addresses of HIV+ people who initially 
consented to participate in the study, of which 246 were completed (a response rate of 60 per 
cent). After selecting the sample to individuals aged 20 to 60, discarded questionnaires that had 
been very incorrectly completed and of patients that were in prison, the valid sample is reduced 
to 219. The characteristics of this sample of individuals are similar to the initial sample of 572 
patients (López-Bastida et al., 2009). It is estimated that this sample represented from 8.3 to 11.3 
per cent of the known HIV+ population in the Canary Islands (Castilla and de la Fuente, 2000).  
 
The date of diagnosis, the most probable cause of infection, defence levels and the current stage 
of the illness (asymptomatic, symptomatic or AIDS) are obtained from the medical records. 
These variables were collected by qualified personnel in the health centres. On the other hand, 
patients themselves fulfilled the questionnaire with information on labour force participation, 
wages, quality of life and socioeconomics characteristics (age, gender, education, number of 
household members, presence of children and other household income). 
 
2.2. Control group 
 
The control group is selected from the sample of 1,153 individuals aged at least 16 from the 
2004 Canary Islands Health Survey (CIHS) and Canary Islands Survey on Income and Living 
Conditions (CISILC). The CIHS and CISILC contain information on the variables we need to 
merge to the records of the treatment group, i.e., demographics, household and individual 
socioeconomic characteristics, labour market outcomes, self-reported health status (EQ-5D), 
diagnosed diseases and utilization of health care services.   
 
Using this representative sample of the general population two control groups are selected. First, 
each individual with HIV is matched to all the individuals from the general population who have 
the same age and gender. Each control individual can be used more than one. Then, we 
construct weights to be used in the regression analysis as follow: 
 
1) Weights are equal to one if the individual is a HIV+ patient 
 
2) For each HIV+ patient i, each of his/her matched control receives weight 1/nci where 
nci is the number of controls matched to HIV+ patient i 
 
3) The final weight used for each control is the overall sum of all the partial weights 
he/she receives to be matched to different treated individuals 
 
We construct the second control group similarly, but we use age, gender and education as exact 
matching variables.  
 
2.3. Variables 
 
Outcomes 
 
Our outcome variables are labour force participation and wages. 
 
Health variables 
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We first control for specific health variables expected to be relevant for the population living 
with HIV, such as defence level or stage of the disease and the most likely cause of infection. 
Clinical history classifies the stages of illness into three levels: asymptomatic HIV (dichotomic 
variable), symptomatic HIV (dichotomic variable) and AIDS (dichotomic variable). The defence 
level is measured by the lymphocytes CD4/µl. The individual base would be the one that showed 
a high defence level in the most recent analytical test (more than 500 CD4s/µl) (we assume that 
individuals of general population are in this category), whereas a low defence level is assigned if 
the patient shows less than 200 lymphocytes CD4/µl and a medium defence level is assigned if 
200<CD4/µl<500. Defence levels and stage of illness cover similar effects as far as the 
classification of the illness is concerned (AIDS stage) which is associated not only to the defence 
level but also to the appearance of an opportunist disease (Ancelle Park, 1993). Most probably 
cause of infection has two categories: Intravenous Drug Use and other causes. People who have 
contracted the disease from Intravenous Drug Use (IDU) might be systematically different to 
those who have contracted it through other means. These systematic differences could in turn 
generate different conditional employment functions that are not exclusively captured by the 
health variables. It would be of interest to disaggregate the other causes of infection but 
unfortunately, the limited size of the sample discourages us to do it. 
 
In addition, we control for self assessed health using a Health Related Quality of Life (HRQOL) 
measure. HRQOL was measure through a generic measure, the EQ-5D questionnaire (Rabin 
and Charro, 2001). The EQ-5D has five questions asking for a self-perceived status of five 
different functional conditions related to mobility, personal care, daily activities, pain 
/discomfort and anxiety /depression. In each dimension, the interviewed person can choose 
between three possible answers: ‘absence of problems’, ‘moderate problems’ and ‘incapacity to 
perform the activity or severe problems’. A respondent health status is defined by combining 
one level from each of the 5 dimensions (EQ-5D). A total of 243 possible health statuses can be 
defined in this way. In order to translate this number to a single health score, a ‘preferences index 
score or tariff’ is needed. This questionnaire has been validated in Spain, and an estimated set a 
score value was obtained using the Time Trade Off method (Badía et al, 1999).  
 
Other explanatory variables 
 
We also control for the effect of other socio-demographic variables as age, sex, education, 
household composition, wages and unearned income. These variables are obtained from a 
specific questionnaire posted to the home addresses of HIV+ people who initially consented to 
participate in the study. As far as unearned income is concerned, this has been defined as the 
difference between total income of the household and the wage of the individual. Thus, this 
variable contains the individual’s unearned income (including sickness or unemployment 
benefits) and the income of other members of the household. 
 
2.4 Descriptive statistics: HIV+ patients, general population and control groups 
 
Table 1 shows the main characteristics of the different samples of analysis. The first column 
shows the mean of the variables of interest for the sample of individuals with HIV+, the second 
column for the full sample of the general population, while columns 3 and 4 show weighted 
means of control group 1 (matched using age and gender) and 2 (matched using age, gender and 
educational attainment). We see that while the age distribution of HIV-positive patients and the 
general population is similar, the percentage of females is clearly lower among the HIV-positive 
patients. By construction, the percentages of males and females in control groups 1 and 2 are the 
same as in the HIV+ population.  
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We find that both average employment rates and wages are similar between HIV-positive 
individuals and general population. However, this similarity is due to the low percentage of 
women in the sample of HIV+ individuals, whose labour force participation is lower compared 
to men. The comparison of the outcome variables between HIV+ and the two control groups 
put forward this effect, as the average employment rate of a sample with the same age-gender 
distribution as our sample of interest is 16.1 percentage points higher, and the wages 247€ 
higher. Similar differences appear when the comparison is done with respect to the sample 
matched in terms of age, gender and educational attainment.  
 
The CD4 count for 6.5 per cent of the HIV+ people was low, 24.6 per cent had a medium CD4 
count, and 68.9 per cent had a high count. A 50.3 per cent of the HIV+ people were in an 
asymptomatic phase, a 24.6 per cent in a symptomatic phase and 25.1 per cent in AIDS phase. 
Intravenous Drug Use was the most likely cause of transmission for 16.6 per cent of HIV+ 
people and sex or blood transfusion were the most likely cause of transmission for 83.4 per cent. 
 
In addition, there are important educational differences between HIV+ patients and the general 
population. We find that while the percentage without education is similar in the two samples, 
the percentage with secondary education is higher in the general population, and correspondingly 
the percentage with primary education is also lower in this sample. Surprisingly, the percentage 
with higher education is similar in the two samples. The high percentage of HIV-positive 
individuals with higher education in our sample is explained by their pattern of infection. Oliva 
(2010) finds that 8.95 per cent of the individuals in the 2001-2004 HHAS sample have passed 
through higher education. However, there are large differences between the two surveys in the 
percentage infected through drug use (55 per cent in the HIV/AIDS Hospital Survey vs. 16.6 
per cent in our sample). Once we control by source of infection, the differences in educational 
attainment between the two samples almost disappear.5 On the other hand, the differences in 
educational attainment between HIV-positive individuals remain with respect to control group 1 
but not with respect to group 2 because one of the variables used for grouping the last one is 
education.  
 
We find that although self reported health status (EQ-5D set score values-TTO method) is 
higher in the general population, it is not very different from the one reported by HIV+ patients. 
Last, HIV+ patients live in households with a smaller sample size (2.3 vs. 3.1) and with lower 
household income from sources other than the individual earnings (470€ vs. 1,238€). 
 
Table 1. Means of HIV+ patients, general population and control groups 1 and 2 
 VIH=1 VIH=0 (all) Control group 1 Control group 2 
Age 40.80 40.57 40.80 40.91 
Female 0.156 0.562 0.156 0.156 
Male 0.844 0.438 0.844 0.844 
No education 0.020 0.017 0.006 0.020 
Primary education 0.422 0.280 0.274 0.422 
Secondary education 0.296 0.502 0.501 0.296 
Higher education 0.261 0.201 0.219 0.261 
Children 0.032 0.1379 0.220 0.193 
Household size 2.342 3.070 3.068 3.082 
Work 0.578 0.550 0.739 0.734 
Wage 2003 592.99 558.21 839.87 846.41 
                                                 
5 Results not shown but available from the authors upon request. 
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Other household 
income 469.75 1237.82 969.12 926.65 
Euroqol (set score value 
TTO Methods) 0.796 0.825 0.842 0.829 
Low cell count 
(CD4/μl<200) 0.065    
Medium CD4 cell count  
(200≤CD4/μl <500) 0.246    
High CD4 cell count 
(CD4/μl≥500) 0.689    
VIH+ Asymptomatic  0.503    
VIH+ Symptomatic 0.246    
AIDS 0.251    
Infected through 
Intravenous Drug Use 
(IDU)  
 
0.166 
   
Infected through sex or 
blood transfusion 
 
0.834 
   
N 199 812 447 275 
Notes. 
1. Mean values for control groups 1 and 2 are obtained using the constructed weights. 
 
 
3. Empirical model 
 
3.1. Specification of the model 
 
The information about labour market variables that we have in our sample relates to the 
indicator of participation and wages of participants. We do not have information on hours that 
could be very useful whenever individuals decide at the intensive margin. Usual labour supply 
models predict responses in hours but neither the evidence shows large responses for healthy 
individuals (see for example Borjas, 1999) nor for unhealthy ones (for instance, Kahn, 1998). 
Moreover, our labour market in Spain is not flexible enough to capture significant responses at 
that level (see Labeaga and Sanz, 2001). Under these considerations, we propose to estimate two 
reduced-form equations of labour force participation and wages, according to the following 
model (that can be derived from a typical neoclassical model of labour supply): 
 
),,,()(1 * iii ZDfh   (1)
 
where )*(1 ih  represents the indicator of participation, *ih  the potential (latent) hours, Di the 
indicator for HIV+ patients, Zi are exogenous individual and household characteristics, as well as 
health indicators and δ and  are parameters. The observability rule is:  
 
                     



 

00
01
*
*
i
i
i hif
if h
h                                                           (2) 
 
and assuming linearity for f(.)  
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iiii uZh D  '*   (3)
 
where h* is a latent variable defining the qualitative nature of h. We assume that the errors ui are 
normally distributed and we use a standard probit model to estimate the parameters of interest.  
 
Similarly, we assume that log(wages) depend linearly on Di, Xi are exogenous characteristics, β and γ parameters and εi is an individual error term, as shown in equation (4)  
 
  iiii XDw   'log         (4) 
 
Information on wages is only observed for the subsample of individuals participating in the 
labour market, which leads to the well-known sample selection problem (Heckman, 1976). We 
follow the standard procedure of assuming joint normality and we estimate the joint model using 
the Heckman´s two step procedure. Equation (4) is then estimated in two stages. At the first 
stage, we fit the reduced form probit model for the participation equation and construct the 
Mill’s ratio using the parameter estimates. Then, at the second we estimate (4) by OLS 
conditional on participation adding the selection term to account for potential endogenous 
selection into participation (Heckman, 1976, 1979). Under joint normality of (ui, εi), full 
information maximum likelihood provides efficient estimates. 
 
3.2. Identification strategy 
 
We face a first identification problem concerning the parameters in a model like (1)-(4). 
Identification could be based on exclusion restrictions and also on the non-linearity of the 
participation equation. In order to identify the parameters at the two stages we use household 
characteristics (household size, other household income, and the presence of children 5 years old 
and younger in the household) as exclusion restrictions. These variables are only included in the 
participation equation but not in the wage equation.  
 
A second challenge has to do with identification of the treatment parameter δ in (3). The effect 
on participation for infected patients should be the difference between the probability observed 
and the probability that we would observe if they were not infected. This last probability is, of 
course, unobserved. Any unobserved factor correlated with the treatment Di could bias the 
parameter estimate thus avoiding identification of causal effects. Several approaches can be used 
to disentangle consequences arising directly from infection from those correlated with infection 
(other health shocks) affecting participation but unobserved to us. Auld (2002) uses repetition of 
observations for the same individuals at the time of infection and some time after the shock. 
Even in these circumstances, he claimed for further research because changes for participation 
or hours of work can be attributed to variations in life expectancy confounded with unobserved 
changes in morbidity. We follow an alternative approach. Since it is not possible to observe the 
counterfactual of working without being affected by the health shock for individuals infected by 
HIV, we built homogeneous control groups and follow the assumption that alternative variables 
(even unobservables) will affect behaviour of controls and treatments in the same way 
(conditional on observables). This last hypothesis is, in our case, non-testable but it is still 
possible to conduct sensitivity analysis using different controls as we do in the empirical section 
below. 
 
4. Results 
 
4.1. Reduced form models 
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Table 2 presents the marginal effects of the probit models of the participation equation. It shows 
the results of four different models.6 In model 1, we study the effects of HIV on labour force 
participation. Models 2 and 3 analyse this effect, but controlling for clinical severity of the health 
status (model 2 by using the stage of illness and model 3 using the level of defences). The high 
correlation between CD4 count and stage of the disease (Ancelle-Park, 1993) prevents them 
from being considered in a single model. So, the variables stage of the disease and CD4+ T-
lymphocyte count could be considered substitutes. The purpose of using both types of indicators 
is to examine whether the estimated marginal coefficients are of a similar magnitude or if they 
vary according to health indicator. Last, model 4 shows the same specification as model 1, but 
only for the subsample of men as they represent 84% of the sample. An indication of the 
confidence of these results is that they are robust across the different specifications. 
 
 
Table 2. Participation results. Marginal effects and standard errors 
 M1 M2 M3 M4 
 
Marginal 
effects 
(SE) 
Marginal 
effects 
(SE) 
Marginal 
effects 
(SE) 
Marginal 
effects 
(SE) 
HIV -0.231(0.057)  
-0.210
(0.063) 
-0.193 
(0.062) 
Most likely cause of transmission 
(IDU) 
-0.280
(0.110) 
-0.271
(0.114) 
-0.261
(0.113) 
-0.268 
(0.124) 
HIV+ asymptomatic  -0.164(0.074)   
HIV+ symptomatic  -0.225(0.086)   
AIDS  -0.413(0.089)   
CD4 cells counts 
(200<CD4s<500)   
0.009
0.074  
CD4 cells counts (CD4s<200)   -0.5640.168  
Age 0.062(0.019) 
0.064
(0.019) 
0.058
(0.019) 
0.059 
(0.021) 
Age2 -0.001(0.000) 
-0.001
(0.000) 
-0.001
(0.000) 
-0.001 
(0.000) 
Female -0.147(0.053) 
-0.140
(0.054) 
-0.151
(0.053)  
Household members -0.042(0.020) 
-0.042
(0.020) 
-0.040
(0.020) 
-0.035 
(0.022) 
Children aged <6 0.068(0.070) 
0.067
(0.070) 
0.064
(0.071) 
0.119 
(0.078) 
Primary education 0.274(0.123) 
0.286
(0.121) 
0.236
(0.122) 
0.352 
(0.131) 
Secondary education 0.358(0.138) 
0.363
(0.137) 
0.313
(0.133) 
0.440 
(0.160) 
Higher education 0.320(0.091) 
0.324
(0.090) 
0.288
(0.095) 
0.359 
(0.093) 
                                                 
6 Since our specifications do not contain wages, we should bear in mind that the results could be inconsistent 
whenever the wage has significant effects on the probability of participating. We estimate participation equations, 
for all samples and specifications, including the predicted log(wage) as an explanatory variable, and find that it is 
highly insignificant. We cannot rule out that the non-significance is due to high collinearity between the predicted 
wage and the other explanatory variables as we don´t have further exclusion restrictions, but we attribute it to the 
diminishing importance of wages in labour supply decisions once an individual has been infected. We do not show 
these results, but they are available from the authors upon request. 
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log(other household income) -0.039(0.006) 
-0.038
(0.006) 
-0.040
(0.007) 
-0.036 
(0.007) 
EQ-5D 0.028(0.097) 
0.008
(0.099) 
0.014
(0.098) 
0.019 
(0.108) 
Number of observations 646 646 646 435 
Log-Likelihood -327.976 -324.526 -322.301 -213.911 
chi2 90.671 93.887 90.636 75.890 
Pseudo R2 0.180 0.189 0.195 0.177 
% correctly predicted 72.91% 72.60% 73.68% 70.28% 
Notes: 
1. Values significantly different from zero in bold typeface (at P<0.05) and italics (at P<0.10). 
 
 
HIV+ has a clearly significant and negative effect on labour force participation, and the 
magnitude of the effect is different depending on both the cause of transmission and/or the 
severity of the illness. As for the cause of infection (when people is HIV+), IDU infected 
persons are distinguished, in terms of participation, from those who have been infected via 
sexual transmission or by blood transfusion. It must be stressed that IDU infected patients have 
an even lower probability of participating (around 27-28 percentage points lower). Thus, the 
probability of participation is decreased 23 per cent if the individual who is HIV+ has been 
infected via sexual transmission or by blood transfusion, but it is decreased by 50-51 percentage 
points when it is an HIV+ individual IDU infected. 
 
On the other hand, Models 2 and 3 add information on the health status (stage of disease and 
CD4 cells counts). As far as the stage of the illness is concerned, we find that the more advanced 
the stage of the illness, the lower is the employment probability, as expected. Thus, the 
employment probability decreases by 16.4 percentage points among asymptomatic HIV patients, 
by 22.5 percentage points among symptomatic HIV patients, and as much as by 41.3 percentage 
points if the person is in the AIDS phase. We find that there are no differences in the probability 
of being employed between HIV+ individuals with medium and high levels of defences. 
However, the probability of being in employment is further decreased by 56.4 percentage points 
if the individual has low levels of CD4 cells counts (CD4s<200). It is important to note that the 
results for the treatment hold even after controlling for subjective and objective health measures 
because it seems to confirm the effect of reducing life expectancy on labour market participation. 
 
The other variables that significantly explain the probability of participating are age, gender, the 
number of household members, educational attainment and unearned income. We see that both 
age and gender have the expected signs. The marginal effect of age shows the usual inverted 
hump-shaped profile: the probability of being employed increases until individuals are aged 29 to 
32 and it decreases thereafter. On the other hand, the likelihood that women participate in the 
labour market is between 14.0 to 15.1 percentage points lower than the one for men.  
 
Educational attainment is positively related with participation in the labour force, and the higher 
increase in the probability of working is found for primary education. The probability of working 
of individuals with primary education is between 23.6 and 28.6 percentage points higher than the 
probability of individuals with no education, and the percentage rises up to 35.2 percentage 
points among the subsample of men. The probability of participation is consequently higher 
among individuals with secondary or higher education compared to individuals with primary 
education, being once again the effects higher among men. This suggests that education may play 
a less important role among females. 
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Unearned income is clearly significant in all the specifications with the expected sign: the higher 
the unearned income, the lower the probability of being employed. We also find that the higher 
the number of household members, the lower the probability of being employed. This is not due 
to the presence of children, as having a child younger than 6 is not associated with the 
probability of being employed (non-significant effect). The effect of household size could reflect 
the availability of other household members to work suggesting the existence of an added 
worker effect. 
 
Finally, regarding the relationship between the health status and the employment probability, we 
find that the EQ-5D presents the expected positive sign (higher health-related quality of life is 
associated with higher probability of being employed) although it is not statistically significant.  
 
Table 3 presents parameter estimates of the specifications of the log-wage equation. The results 
of Models 1 to 4 discussed above are also shown here and they are also robust across the 
different specifications. The Mill´s ratio included in each of the models is obtained from the 
corresponding participation equation. It is marginally significant and has a moderate positive 
effect, which could be relevant at the time of correctly predicting wages that are going to be used 
as instruments. 
 
 
Table 3. Parameter estimates, log-wage equation 
 M1 M2 M3 M4 
 Coefficient
(SE) 
Coefficient
(SE) 
Coefficient 
(SE) 
Coefficient
(SE) 
HIV -0.091(0.052)  
-0.084
(0.056) 
-0.127
(0.057) 
Most likely cause of 
transmission (IDU) 
-0.249
(0.147) 
-0.240
(0.153) 
-0.266
(0.148) 
-0.198
(0.158) 
HIV+ asymptomatic  -0.088(0.060)   
HIV+ symptomatic  -0.085(0.080)   
AIDS  -0.161(0.157)   
CD4 cells counts 
(200<CD4s<500)   
-0.046
(0.111)  
CD4 cells counts 
(CD4s<200)   
-0.019
(0.107)  
Age 0.005(0.003) 
0.006
(0.003) 
0.006
(0.003) 
0.004 
(0.004) 
Female -0.160(0.060) 
-0.157
(0.060) 
-0.161
(0.061)  
Primary education 0.501(0.108) 
0.502
(0.110) 
0.511
(0.109)  
Secondary education 0.552(0.105) 
0.551
(0.107) 
0.562
(0.105) 
0.063 
(0.060) 
Higher education 0.854(0.108) 
0.853
(0.109) 
0.864
(0.109) 
0.344 
(0.071) 
Euroqoltet 0.105(0.079) 
0.106
(0.079) 
0.109
(0.079) 
0.175 
(0.087) 
Mills (λ) 0.098(0.050) 
0.102
(0.051) 
0.094
(0.050) 
0.098 
(0.053) 
Number of observations 399 399 399 282 
Adjusted R2 0.186 0.184 0.182 0.164 
Notes. 
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1. Values significantly different from zero in bold typeface (at P<0.05) and italics (at P<0.10). 
2. In order to identify the parameters of the log wage and participation equations, household size, other 
household income, and the presence of children 5 years old and younger in the household are 
excluded from the log wage equation. 
 
 
The results show that HIV+ individuals not only have lower participation rates, but also lower 
wages if employed. The decrease in wages is associated with the cause of infection; wages of 
HIV+ individuals infected via sexual transmission or by blood transfusion are 9% lower 
compared to non-HIV+ individuals, while wages of IDU infected patients are 34% lower. The 
robustness of these effects as well as the differences found could confirm some kind of 
discrimination since the employer could have some information about the health shock. On the 
other hand, the severity of the illness seems not to be related with the level of wages, as we find 
no significant effects associated to the different stages of the disease, as well as to the different 
level of CD4 counts.  
 
The estimated coefficients of the other explanatory variables show the expected sign. Age is 
positively related to higher wages, women receive lower wages and the higher the educational 
attainment, the higher the wage. Last, higher self-reported health is associated with higher wages, 
although the effect is only significant for the subsample of men. 
 
4.2. Results using the second control group 
 
In order to assess the robustness of our results to the choice of the control group, tables 4 and 5 
show the estimated parameters when the second control group is used (individuals in the control 
group are matched on age, gender and educational attainment). We find that the results remain 
the same not only regarding the sign, but also the magnitude of the effect of the variables of 
interest.  
 
 
Table 4. Participation equation. Control group 2 
 M1 M2 M3 M4 
 
Marginal 
effects 
(SE) 
Marginal 
effects 
(SE) 
Marginal 
effects 
(SE) 
Marginal 
effects 
(SE) 
HIV -0.253(0.066)  
-0.231 
(0.072) 
-0.236 
(0.068) 
Most likely cause of transmission (IDU) -0.255(0.108) 
-0.245
(0.112) 
-0.243 
(0.112) 
-0.235 
(0.122) 
HIV+ asymptomatic  
-0.194
(0.084)   
HIV+ symptomatic  
-0.245
(0.095)   
AIDS  
-0.427
(0.095)   
CD4 cells counts (200<CD4s<500)   
0.006 
(0.078)  
CD4 cells counts (CD4s<200)   
-0.576 
(0.147)  
Number of observations 474 474 474 368 
Log-Likelihood -248.53 -245.46 -242.51 -185.87 
chi2 72.225 72.979 71.603 53.477 
Pseudo R2 0.175 0.185 0.195 0.163 
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% correctly predicted 72.15% 73.42% 74.47% 70.46%
Notes. 
1. Values significantly different from zero in bold typeface (at P<0.05) and italics (at P<0.10). 
2. The same explanatory variables as shown in Table 2 are included in the estimation. 
 
 
Table 5. Wage equation. Control group 2 
 M1 M2 M3 M4 
 Coefficient
(SE) 
Coefficient
(SE) 
Coefficient 
(SE) 
Coefficient
(SE) 
HIV -0.089(0.059)  
-0.086
(0.058) 
-0.117
(0.058) 
Most likely cause of 
transmission (IDU) 
-0.236
(0.147) 
-0.228
(0.153) 
-0.254
(0.149) 
-0.156
(0.157) 
HIV+ asymptomatic  -0.094(0.061)   
HIV+ symptomatic  -0.082(0.081)   
AIDS  -0.134(0.158)   
CD4 cells counts 
(200<CD4s<500)   
-0.047
(0.111)  
CD4 cells counts 
(CD4s<200)   
0.044
(0.134)  
Number of observations 295 295 295 245 
Adjusted R2 0.200 0.198 0.194 0.215 
Notes. 
1. Values significantly different from zero in bold typeface (at P<0.05) and italics (at P<0.10). 
2. The same explanatory variables as shown in Table 3 are included in the estimation.  
 
 
5. Discussion and concluding remarks  
 
The introduction of Highly Active Anti-Retroviral Treatments to treat individuals living with 
HIV/AIDS has improved not only their health status, but also their employment rates. 
However, the employment rates of HIV/AIDS patients are still lower than those of the general 
population. In this study, we analyse the effect of HIV/AIDS on the employment rate of those 
living with HIV/AIDS using a control group with similar socio-demographic characteristics. In 
addition, we investigate the importance of the stage of the disease using two alternative 
indicators (stage of disease and levels of defence) and using an indicator that reflects the marked 
influence of unobserved factors (most likely cause of infection). To the best of our knowledge, 
this is the first paper that uses a control group in the HAART era to investigate those effects.  
 
HIV+ has a clearly significant and negative effect on labour force participation and the 
magnitude of the effect is different depending on both the cause of transmission and/or the 
severity of the illness. The probability of participation is decreased by 23 percentage points if the 
individual who is HIV+ has been infected via sexual transmission or by blood transfusion, but it 
is strongly decreased (by 50-51 percentage points) when it is an HIV+ individual IDU infected. 
As far as the stage of the illness is concerned, we find that the more advanced the stage of the 
illness, the lower is the employment probability. Thus, the employment probability decreases by 
16.4 percentage points among asymptomatic HIV patients, by 22.5 percentage points among 
symptomatic HIV patients, and as much as by 41.3 percentage points if the person is in the 
AIDS phase and the probability of being in employment is further decreased by 56.4 percentage 
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points if the individual has low levels of CD4 cells counts (CD4s<200). On the other hand, 
HIV+ individuals not only have lower participation rates, but also lower wages if employed. The 
decrease in wages is associated with the cause of infection; although the severity of the illness 
seems not to be related with the level of wages. These results are robust to the choice of the 
control group both qualitative and quantitatively. They suggest that some discrimination by the 
employers could be at stake, as the differences exist after conditioning on the exact same 
distribution of age, gender and educational attainment. 
 
A common conclusion in the empirical literature is that patients diagnosed before the HAART 
era may have stopped working under the assumption that the health damage was irreversible. 
The results found in this paper confirm that wages are not important in the labour supply of 
HIV infected patients, while in addition to the stage of the illness other household income seems 
crucial. Other important factors include some socio-demographic characteristics and health 
variables. While the effects of HIV/AIDS on participation are now smaller than in the past, 
there could still be an effect at time of the diagnosis (due to the effect of new information about 
reduced life expectancy) as well as with the evolution of the illness (which also affects life 
expectancy). We do the exercise comparing treated and control groups based on a selection of 
observable socioeconomic characteristics, thus the results are not contaminated by their 
confounding effects. Still, unobserved factors differently affecting the two groups could bias the 
result of the treatment parameter whenever those factors are correlated with the HIV infection. 
 
In light of our results, we cannot affirm that HIV infected patients are going to be more socially 
vulnerable or are going to be at risk of exclusion. But their participation rates are lower than 
those from non-infected individuals from the general population with the same characteristics, 
and they get lower wages when participating than their healthy counterparts. Since it is not 
possible for us to confirm whether lower participation is a consequence of lower life expectancy 
(poorer health status) or the lower demand of employers towards HIV infected patients, we will 
not only support public education policies on healthy habits but also public non-discriminating 
policies on employment and wages of this vulnerable population. This way of acting, 
independently of the form of infection, will ensure equity as well as lower risk of poverty and 
social exclusion. 
 
This study is not exempt from limitations. First, the small sample size suggests proceeding with a 
certain amount of caution with the conclusions. Second, some relevant variables such as mental 
health and the intensity of the psychological affliction were not available. Third, the 
characteristics of our sample slightly differ from the characteristics of the Spanish HIV+ 
population shown in other studies (Oliva 2010), as the percentage of women and the share of the 
patients infected for intravenous drug use are lower in this survey. This is mainly due to the non-
inclusion of hospitalized and imprisoned individuals in our sample, whereas the Hospital 
HIV/AIDS Survey (HHAS) includes them. Representativeness of the survey is of special 
importance when trying to extrapolate conclusions to the HIV-positive population. In our case, 
the patients’ profile fits with the new cases of HIV diagnosed in the last decade according to the 
Spanish HIV-epidemiological surveillance (Centro Nacional de Epidemiología, 2011). Therefore, 
our results are likely to be able to forecast the future employment outcomes of new cases of 
infection. In addition, the use of data from patients who attend the outpatient public health care 
services should not be considered a weakness of the study as most patients will belong to this 
group given the chronic nature of the illness. Finally, our results were obtained from two cross-
sectional surveys performed in the Canary Islands (Spain). Obviously, it would have been 
preferable to have longitudinal databases, where HIV-positive persons and a control group could 
be followed for several years but, unfortunately, this type of survey went beyond our means. 
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Despite these limitations, these results may serve as the basis for making medium term 
predictions and for the design of integral policies. These policies should go beyond isolated 
public health policies or strictly employment policies, but joint efforts from the two sectors 
would be needed in order to improve the well-being and opportunities of people with this health 
problem to integrate in society with all their rights and without the risk of suffering from 
discrimination.  
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